House: Activity We Track

House: Activity We Track

Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration SCOTUS Amicus Brief

This pro-life amicus brief asks the Supreme Court of the United States to deny a stay on a 5th Circuit ruling that would have returned chemical abortion drugs to the 2016 safety protocols, ending reckless and illegal mail-order abortion. The Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration case was brought by doctors and health groups who sued the FDA over its improper approval of chemical abortion drugs and the reckless removal of safety protocols in the years since the original approval. The FDA did not adhere to its own standards of approvals, when pressured by the Clinton administration to make the chemical abortion drug available in America. The Obama administration further pressured the FDA to remove safety protocols, and the Biden administration has recklessly made these drugs available without in-person screenings, through the mail, leaving women and girls at greater risk of dangerous complications.

 

H.R. 7, No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023 – Cosponsorship

H.R. 7 would codify the Hyde Amendment, by establishing a permanent, government-wide prohibition on federal funding for abortion, prohibiting federal subsidies in the form of Obamacare tax credits for health plans that include abortion, and strengthening disclosure requirements for plans that include abortion. SBA Pro-Life America strongly supports this bill and urges Members to cosponsor it. Cosponsorship demonstrates recognition of the importance of this legislation.

 

H.R. 427, the Support and Value Expectant (SAVE) Moms and Babies Act of 2023 – Cosponsorship

H.R. 427 would prevent approval of new abortion drugs by the U.S. Food and Drug Administration (FDA), prohibit the FDA from removing safety regulations of already-approved abortion drugs, and stop abortion drugs from being dispensed remotely by mail or through telemedicine. The abortion industry’s drastic shift to chemical self-abortion is deeply disturbing as it carries with it the possibility of increasing the rate of abortion over time and carries with it a higher rate of injury, about which women are often underinformed or deceived. SBA Pro-Life America strongly supports this bill and urges Members to cosponsor it. Cosponsorship demonstrates recognition of the importance of this legislation.

House: Activity We Track

H.R. 554, the Support and Value Expectant Moms and Babies Act – Cosponsorship

H.R. 554 would prevent approval of new abortion drugs by the U.S. Food and Drug Administration (FDA), prevent the loosening of FDA regulation of already-approved abortion drugs, and prevent abortion drugs from being dispensed remotely by mail or through telemedicine. The abortion industry’s migration to chemical self-abortion is deeply disturbing as it carries with it the possibility of increasing the rate of abortion over time and carries with it a higher rate of injury, about which women are often underinformed or deceived. SBA Pro-Life America strongly supports this bill and urges Members to cosponsor it. Cosponsorship demonstrates recognition of the importance of this legislation.

H.R. 18, the No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act – Cosponsorship

H.R. 18 would codify the Hyde Amendment, by establishing a permanent, government-wide prohibition on federal funding for abortion, prohibiting federal subsidies in the form of Obamacare tax credits for health plans that include abortion, and strengthening disclosure requirements for plans that include abortion. SBA Pro-Life America strongly supports this bill and urges Members to cosponsor it. Cosponsorship demonstrates recognition of the importance of this legislation.

H.R. 1080, the Pain-Capable Unborn Child Protection Act – Cosponsorship

H.R. 1080 would protect unborn children halfway through pregnancy based on their ability to feel excruciating pain. Previous uninformed notions that unborn and newborn babies could not feel pain, or misinformation on the ability of preterm infants to survive, are refuted by a growing body of scientific evidence. The Pain-Capable bill is an important step in matching our public policy with the growing body of scientific evidence of pain and advancing perinatal medicine. SBA Pro-Life America strongly supports H.R. 1080 and urges cosponsorship. Cosponsorship demonstrates recognition of the importance of this legislation.

Hyde Amendment Letter

SBA Pro-Life America strongly supported a letter opposing Congressional Democrats’ efforts to repeal the Hyde Amendment and other pro-life protections in the annual spending bills. The Hyde Amendment and its family of pro-life protections have been upheld by members of Congress and presidents of both parties for over four decades. Hyde alone is responsible for the saving of nearly 2.5 million lives. This letter pledges to vote against any government funding bill that weakens or eliminates any of these provisions.

McMorris Rogers/Walorski/Foxx Amendment #167– Cosponsorship

This amendment would apply the Hyde and Helms amendments to the unprotected funding streams of the Budget Reconciliation COVID relief bill (the so-called American Rescue Plan Act), to ensure taxpayer funding could not subsidize abortion domestically or internationally. It would prevent government subsidized abortion coverage through COBRA. While all prior bipartisan COVID relief packages had included Hyde protections on their funding streams, the American Rescue Plan Act departed from the status quo by leaving funds open to use for abortion, and subsidizing abortion coverage through COBRA and Obamacare. Additionally, the foreign assistance funding is exempted from the Helms amendment, which prohibits funding for abortion internationally. SBA Pro-Life America strongly opposed this expansion of funding for abortion, and strongly supported this amendment to stop the funding for abortion through COVID relief. Cosponsorship of this amendment is considered is a pro-life vote.

Dobbs v. Jackson Women’s Health Organization Congressional amicus brief

The Supreme Court has agreed to take up a Mississippi late-term abortion case, Dobbs v. Jackson Women’s Health Organization, in the October 2021 term. The question being considered in this historic case is “Whether all pre-viability prohibitions on elective abortions are unconstitutional.” The Congressional pro-life amicus brief specifically argues the faulty reasoning of the viability standard: it remains undefined by the court, it has been relied on as a prohibition on regulating abortion, and it restricts legislators from furthering critical state interests. Further, the brief argues that the viability standard prevents reasonable regulations for protecting: women’s health; unborn children from pain during late-term abortions; the medical profession; and states’ ability to prevent discrimination abortion based on disability. Finally, it asks that Roe v. Wade and Planned Parenthood v. Casey be reconsidered, and if appropriate, wholly or partially overruled.

H.R. 705, Heartbeat Protection Act of 2021 – Cosponsorship

The Heartbeat Protection Act would establish protections for unborn children when a fetal heartbeat can be detected, except in cases when the life of the mother is endangered. The heart is the child’s first functioning organ—at around six weeks gestation, the embryo’s heart is beating rhythmically to pump blood throughout the tiny body. Susan B. Anthony Pro-Life America strongly supports this bill and urges Members to cosponsor it. Cosponsorship demonstrates recognition of the importance of this legislation.

H.R. 8814, Protecting Pain-Capable Unborn Children from Late-Term Abortions Act – Cosponsorship

H.R. 8814 would protect unborn children at 15 weeks’ gestation based on new science proving their ability to feel excruciating pain at least by this point. Previous uninformed notions that unborn and newborn babies could not feel pain have been refuted by a growing body of scientific evidence. The Protecting Pain-Capable Unborn Children bill is an important step both in matching our public policy with the growing body of scientific evidence of pain and advancing perinatal medicine and in responding to the overturning of Roe v. Wade. SBA Pro-Life America strongly supports H.R. 8814 and urges cosponsorship. Cosponsorship demonstrates recognition of the need for federal limits on abortion to protect the unborn in this new Dobbs era.

House: Activity We Track

H.R. 4399, the Support and Value Expectant Moms and Babies Act – Cosponsorship

H.R. 4399 would prevent approval of new abortion drugs by the U.S. Food and Drug Administration (FDA), prevent the loosening of FDA regulation of already-approved abortion drugs, and prevent abortion drugs from being dispensed remotely by mail or through telemedicine. The abortion industry’s migration to chemical self-abortion is deeply disturbing as it carries with it the possibility of increasing the rate of abortion over time and carries with it a higher rate of injury, about which women are often underinformed or deceived. SBA Pro-Life America strongly supports this bill and urges Members to cosponsor it. Cosponsorship demonstrates recognition of the importance of this legislation.

H.R. 20, the No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act – Cosponsorship

H.R. 20 would codify the Hyde Amendment, by establishing a permanent, government-wide prohibition on federal funding for abortion, prohibiting federal subsidies in the form of Obamacare tax credits for health plans that include abortion, and strengthening disclosure requirements for plans that include abortion. SBA Pro-Life America strongly supports this bill and urges Members to cosponsor it. Cosponsorship demonstrates recognition of the importance of this legislation.

H.R. 784, the Pain-Capable Unborn Child Protection Act – Cosponsorship

H.R. 784 would protect unborn children halfway through pregnancy based on their ability to feel excruciating pain. Previous uninformed notions that unborn and newborn babies could not feel pain, or misinformation on the ability of preterm infants to survive, are refuted by a growing body of scientific evidence. The Pain-Capable bill is an important step in matching our public policy with the growing body of scientific evidence of pain and advancing perinatal medicine. SBA Pro-Life America strongly supports H.R. 784 and urges cosponsorship. Cosponsorship demonstrates recognition of the importance of this legislation.

Letter to President Donald J. Trump

SBA Pro-Life America strongly supported this letter by pro-life Representatives calling on the President to veto any legislation that comes to his desk that weakens pro-life protections on taxpayer funding or any other federal policy on abortion. Presidents George H.W. Bush and George W. Bush signed similar letters during their presidencies. This preemptive guarantee, which President Trump announced in January 2019 was critical given the new pro-abortion majority in the House of Representatives. SBA Pro-Life America strongly supported this letter and urged Members to sign it. Signing this letter demonstrates the recognition of the importance of defending pro-life policies.

Letter opposing funding for fetal tissue research

SBA Pro-Life America strongly supported a letter thanking the president for his strong stance on excluding funding for research involving aborted fetal tissue and urging his continued resolve. Abortion activists and public officials used the coronavirus pandemic to push back against this life-affirming position, saying fetal tissue was necessary to find a cure. Despite these claims, the best science doesn’t involve fetal tissue, and many potential cures for the coronavirus are already being researched using ethical science.

Bicameral letter regarding chemical abortion restrictions

SBA Pro-Life America strongly supported a letter encouraging FDA Commissioner to uphold restrictions on the dispensing of chemical abortion put in place for the safety of women. Abortion activists and public officials used the coronavirus pandemic as an excuse to call for making self-managed abortion more accessible to women. In response, this letter points out the that chemical abortion is riskier than surgical abortion for moms, not to mention the fatal result for each unborn child. The FDA’s requirements for the dispensing of chemical abortion drugs are necessary to protect women.